Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2022 | MiNDCAFE | $17.0M Series B | Hashed | E&Investment, Insight Equity Partners, K2 Investment, Samsung Next |
| Feb 1, 2021 | Artiva Biotherapeutics | $120.0M Series B | Venrock | 5AM Ventures, Frazier Healthcare Partners, RA Capital, venBio, Acuta Capital Partners, Cormorant Asset Management, EcoR1 Capital, Franklin Templeton, Green Cross LabCell, Janus Henderson Investors, Logos Capital, RA Capital Management, RTW Investments, Surveyor Capital, Wellington Management |
| May 13, 2015 | Juventas Therapeutics | $13.5M Debt / Series B | Green Cross Holdings, POSCO Technology Investment | Oxford Finance |
| Nov 20, 2013 | Argos Therapeutics | $17.5M Series E Extension | — | Aurora Funds, Forbion, Intersouth Partners, Lumira Ventures, Morningside, Pharmstandard International, TVM Capital |
| Aug 28, 2013 | Argos Therapeutics | $42.5M Series E | Alexandr Shuster | Aurora Funds, Forbion, Intersouth Partners, Lumira Ventures, Morningside, TVM Capital |